Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 82
Filter
1.
PLoS One ; 16(9): e0256863, 2021.
Article in English | MEDLINE | ID: mdl-34492058

ABSTRACT

In both the pharmaceutical and agricultural fields, RNA-based products have capitalized upon the mechanism of RNA interference for targeted reduction of gene expression to improve phenotypes and traits. Reduction in gene expression by RNAi is the result of a small interfering RNA (siRNA) molecule binding to an ARGONAUTE (AGO) protein and directing the effector complex to a homologous region of a target gene's mRNA. siRNAs properties that govern RNA-AGO association have been studied in detail. The siRNA 5' nucleotide (nt) identity has been demonstrated in plants to be an important property responsible for directing association of endogenous small RNAs with different AGO effector proteins. However, it has not been investigated whether the 5' nt identity is an efficacious determinant for topically-applied chemically synthesized siRNAs. In this study, we employed a sandpaper abrasion method to study the silencing efficacies of topically-applied 21 base-pair siRNA duplexes. The MAGNESIUM CHELATASE and GREEN FLUORESCENT PROTEIN genes were selected as endogenous and transgenic gene targets, respectively, to assess the molecular and phenotypic effects of gene silencing. Collections of siRNA variants with different 5' nt identities and different pairing states between the 5' antisense nt and its match in the sense strand of the siRNA duplex were tested for their silencing efficacy. Our results suggest a flexibility in the 5' nt requirement for topically applied siRNA duplexes in planta and highlight the similarity of 5' thermodynamic rules governing topical siRNA efficacy across plants and animals.


Subject(s)
Argonaute Proteins/genetics , Nicotiana/genetics , RNA Interference , RNA, Small Interfering/genetics , Argonaute Proteins/antagonists & inhibitors , Gene Expression Regulation/genetics , Gene Silencing , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/genetics , Humans , Lyases/antagonists & inhibitors , Lyases/genetics , Protein Binding/genetics , Nicotiana/growth & development
2.
PLoS One ; 16(3): e0245422, 2021.
Article in English | MEDLINE | ID: mdl-33720987

ABSTRACT

Gene silencing in plants using topical dsRNA is a new approach that has the potential to be a sustainable component of the agricultural production systems of the future. However, more research is needed to enable this technology as an economical and efficacious supplement to current crop protection practices. Systemic gene silencing is one key enabling aspect. The objective of this research was to better understand topically-induced, systemic transgene silencing in Nicotiana benthamiana. A previous report details sequencing of the integration site of the Green Fluorescent Protein (GFP) transgene in the well-known N. benthamiana GFP16C event. This investigation revealed an inadvertent co-integration of part of a bacterial transposase in this line. To determine the effect of this transgene configuration on systemic silencing, new GFP transgenic lines with or without the transposase sequences were produced. GFP expression levels in the 19 single-copy events and three hemizygous GFP16C lines produced for this study ranged from 50-72% of the homozygous GFP16C line. GFP expression was equivalent to GFP16C in a two-copy event. Local GFP silencing was observed in all transgenic and GFP16C hemizygous lines after topical application of carbon dot-based formulations containing a GFP targeting dsRNA. The GFP16C-like systemic silencing phenotype was only observed in the two-copy line. The partial transposase had no impact on transgene expression level, local GFP silencing, small RNA abundance and distribution, or systemic GFP silencing in the transgenic lines. We conclude that high transgene expression level is a key enabler of topically-induced, systemic transgene silencing in N. benthamiana.


Subject(s)
Gene Silencing , Green Fluorescent Proteins/genetics , Nicotiana/genetics , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/metabolism , Hemizygote , Homozygote , Phenotype , Plant Leaves/genetics , Plant Leaves/metabolism , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , RNA, Double-Stranded/metabolism , Nicotiana/metabolism
3.
ACS Appl Mater Interfaces ; 12(50): 55554-55563, 2020 Dec 16.
Article in English | MEDLINE | ID: mdl-33259200

ABSTRACT

Advances in the DNA nanotechnology have enabled the fabrication of DNA-based hydrogels with precisely controlled structures and tunable mechanical and biological properties. Compared to DNA hydrogel, preparation of RNA-based hydrogel remains challenging due to the inherent instability of naked RNA. To overcome these limitations, we fabricated a DNA-RNA hybrid hydrogel via stepwise dual enzymatic polymerization. Multimeric short hairpin RNAs (shRNAs) were hybridized with functional DNA aptamers for targeting and mechanical properties of the hydrogel. The obtained DNA-RNA hybrid hydrogel was ultrasoft, robust, and injectable hence reconfigurable into any confined structures. As a model system, the hydrogel was able to mimic microtubule structures under physiological conditions and designed to release the functional small interfering RNA (siRNA)-aptamer complex (SAC) sequentially. In addition, we encoded restriction enzyme-responsive sites in DNA-RNA hybrid hydrogel to boost the release of SAC. This novel strategy provides an excellent platform for systematic RNA delivery through double-controlled release, SAC release from hydrogel, and subsequent release of siRNA from the SAC, which has promising potential in RNA therapy.


Subject(s)
Aptamers, Nucleotide/chemistry , Hydrogels/chemistry , RNA, Small Interfering/chemistry , Animals , Aptamers, Nucleotide/metabolism , Drug Carriers/chemistry , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HeLa Cells , Humans , Mice , Mice, Nude , Optical Imaging , RNA Interference , RNA, Small Interfering/metabolism , Transplantation, Heterologous
4.
J Biosci ; 452020.
Article in English | MEDLINE | ID: mdl-32975236

ABSTRACT

The cotton bollworm, Helicoverpa armigera, is a highly polyphagous pest, causing enormous losses to various economically important crops. The identification and in vitro functional validation of target genes of a pest is a prerequisite to combat pest via host-mediated RNA interference (RNAi). In the present study, six hormonal biosynthesis genes of H. armigera were chosen and evaluated by feeding insect larvae with dsRNAs corresponding to each target gene, viz., juvenile hormone acid methyltransferase (HaJHAMT), prothoracicotropic hormone (HaPTTH), pheromone biosynthesis-activating peptide (HaPBAP), molt regulating transcription factor (HaHR3), activated protein 4 (HaAP-4) and eclosion hormone precursor (HaEHP). The loss of function phenotypes for these hormonal genes were observed by releasing second instar larvae on to artificial diet containing target gene-specific dsRNAs. Ingestion of dsRNAs resulted in mortality ranging from 60% to 90%, reduced larval weight, phenotypic deformities and delayed pupation. The quantitative real-time PCR (qRT-PCR) analysis showed that the target gene transcript levels were decreased drastically (31% to 77%) as compared to control or unrelated control (GFP-dsRNA), and correlated well with the mortality and developmental defects of larvae. Also, a comparison of the silencing efficacy of un-diced long HaPTTH -dsRNAwith RNase III diced HaPTTH-dsRNA (siRNAs) revealed that long dsRNAs were more efficient in silencing the target gene. These results indicated that the hormonal biosynthesis genes have varied sensitivity towards RNAi and could be the vital targets for insect resistance in crop plants like cotton which are infested by H. armigera.


Subject(s)
Insect Control/methods , Insect Proteins/antagonists & inhibitors , Larva/genetics , Moths/genetics , RNA Interference , RNA, Messenger/genetics , Animals , Gene Expression Regulation, Developmental , Genes, Reporter , Gossypium/parasitology , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Insect Hormones/antagonists & inhibitors , Insect Hormones/genetics , Insect Hormones/metabolism , Insect Proteins/genetics , Insect Proteins/metabolism , Larva/growth & development , Larva/metabolism , Longevity/genetics , Methyltransferases/antagonists & inhibitors , Methyltransferases/genetics , Methyltransferases/metabolism , Moths/growth & development , Moths/metabolism , Neuropeptides/antagonists & inhibitors , Neuropeptides/genetics , Neuropeptides/metabolism , RNA, Double-Stranded/genetics , RNA, Double-Stranded/metabolism , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/metabolism
6.
Sci Rep ; 10(1): 6239, 2020 04 10.
Article in English | MEDLINE | ID: mdl-32277083

ABSTRACT

Green fluorescent proteins (GFPs) are widely used in biological research. Although GFP can be visualized easily, its precise manipulation through binding partners is still burdensome because of the limited availability of high-affinity binding partners and related structural information. Here, we report the crystal structure of GFPuv in complex with the anti-GFP nanobody LaG16 at 1.67 Å resolution, revealing the details of the binding between GFPuv and LaG16. The LaG16 binding site was on the opposite side of the GFP ß-barrel from the binding site of the GFP-enhancer, another anti-GFP nanobody, indicating that the GFP-enhancer and LaG16 can bind to GFP together. Thus, we further designed 3 linkers of different lengths to fuse LaG16 and GFP-enhancer together, and the GFP binding of the three constructs was further tested by ITC. The construct with the (GGGGS)4 linker had the highest affinity with a KD of 0.5 nM. The GFP-enhancer-(GGGGS)4-LaG16 chimeric nanobody was further covalently linked to NHS-activated agarose and then used in the purification of a GFP-tagged membrane protein, GFP-tagged zebrafish P2X4, resulting in higher yield than purification with the GFP-enhancer nanobody alone. This work provides a proof of concept for the design of ultra-high-affinity binders of target proteins through dimerized nanobody chimaeras, and this strategy may also be applied to link interesting target protein nanobodies without overlapping binding surfaces.


Subject(s)
Chromatography, Affinity , Green Fluorescent Proteins/antagonists & inhibitors , Protein Engineering/methods , Single-Domain Antibodies/genetics , Affinity Labels/metabolism , Amino Acid Sequence/genetics , Binding Sites/genetics , Crystallography, X-Ray , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Green Fluorescent Proteins/ultrastructure , Receptors, Purinergic P2X4 , Single-Domain Antibodies/metabolism , Single-Domain Antibodies/ultrastructure , Structure-Activity Relationship , Zebrafish Proteins/genetics , Zebrafish Proteins/isolation & purification
7.
Toxins (Basel) ; 12(2)2020 02 14.
Article in English | MEDLINE | ID: mdl-32075080

ABSTRACT

Abrin is a highly potent and naturally occurring toxin produced in the seeds of Abrus precatorius (Rosary Pea) and is of concern as a potential bioterrorism weapon. There are many rapid and specific assay methods to detect this toxic plant protein, but few are based on detection of toxin activity, critical to discern biologically active toxin that disables ribosomes and thereby inhibits protein synthesis, producing cytotoxic effects in multiple organ systems, from degraded or inactivated toxin which is not a threat. A simple and low-cost CCD detector system was evaluated with colorimetric and fluorometric cell-based assays for abrin activity; in the first instance measuring the abrin suppression of mitochondrial dehydrogenase in Vero cells by the MTT-formazan method and in the second instance measuring the abrin suppression of green fluorescent protein (GFP) expression in transduced Vero and HeLa cells. The limit of detection using the colorimetric assay was 10 pg/mL which was comparable to the fluorometric assay using HeLa cells. However, with GFP transduced Vero cells a hundred-fold improvement in sensitivity was achieved. Results were comparable to those using a more expensive commercial plate reader. Thermal inactivation of abrin was studied in PBS and in milk using the GFP-Vero cell assay. Inactivation at 100 °C for 5 min in both media was complete only at the lowest concentration studied (0.1 ng/mL) while treatment at 63 °C for 30 min was effective in PBS but not milk.


Subject(s)
Abrin/isolation & purification , Abrus/chemistry , Colorimetry/methods , Plants, Toxic/chemistry , Seeds/chemistry , Toxins, Biological/isolation & purification , Abrin/toxicity , Animals , Biocatalysis , Chlorocebus aethiops , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/genetics , HeLa Cells , Humans , Image Interpretation, Computer-Assisted , Mitochondria/drug effects , Mitochondria/enzymology , Oxidoreductases/metabolism , Sensitivity and Specificity , Toxins, Biological/toxicity , Vero Cells
8.
Nucleic Acids Res ; 48(1): e2, 2020 01 10.
Article in English | MEDLINE | ID: mdl-31680162

ABSTRACT

The lack of endogenous RNAi machinery in the malaria parasite Plasmodium hampers gene annotation and hence antimalarial drug and vaccine development. Here, we engineered rodent Plasmodium berghei to express a minimal, non-canonical RNAi machinery that solely requires Argonaute 2 (Ago2) and a modified short hairpin RNA, so-called AgoshRNA. Using this strategy, we achieved robust and specific gene knockdown throughout the entire parasite life cycle. We also successfully silenced the endogenous gene perforin-like protein 2, phenocopying a full gene knockout. Transcriptionally restricting Ago2 expression to the liver stage further enabled us to perform a stage-specific gene knockout. The RNAi-competent Plasmodium lines reported here will be a valuable resource for loss-of-function phenotyping of the many uncharacterized genes of Plasmodium in low or high throughput, without the need to engineer the target gene locus. Thereby, our new strategy and transgenic Plasmodium lines will ultimately benefit the discovery of urgently needed antimalarial drug and vaccine candidates. Generally, the ability to render RNAi-negative organisms RNAi-competent by mere introduction of two components, Ago2 and AgoshRNA, is a unique paradigm that should find broad applicability in other species.


Subject(s)
Argonaute Proteins/genetics , Genetic Engineering/methods , Plasmodium berghei/genetics , Protozoan Proteins/genetics , RNA Interference , RNA, Small Interfering/genetics , Animals , Anopheles/parasitology , Argonaute Proteins/metabolism , Female , Genes, Reporter , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Life Cycle Stages/genetics , Mice , Mice, Inbred C57BL , Mosquito Vectors/parasitology , Organisms, Genetically Modified , Perforin/genetics , Perforin/metabolism , Plasmodium berghei/growth & development , Plasmodium berghei/metabolism , Protozoan Proteins/antagonists & inhibitors , Protozoan Proteins/metabolism , RNA, Small Interfering/metabolism , Transgenes
9.
Sci Rep ; 9(1): 16875, 2019 11 14.
Article in English | MEDLINE | ID: mdl-31728030

ABSTRACT

The higher-order architecture observed in biological systems, like viruses, is very effective in nucleic acid transport. The replications of this system has been attempted with both synthetic and naturally occurring polymers with mixed results. Here we describe a peptide/siRNA quaternary complex that functions as an siRNA delivery system. The rational design of a peptide assembly is inspired by the viral capsids, but not derived from them. We selected the collagen peptide (COL) to provide the structural stability and the folding framework, and hybridize it with the cell penetrating peptide (CPP) that allows for effective penetration of biological barriers. The peptide/siRNA quaternary complex forms stoichiometric, 10 nm nanoparticles, that show fast cellular uptake (<30 min), effective siRNA release, and gene silencing. The complex provides capsid-like protection for siRNA against nucleases without being immunostimulatory, or cytotoxic. Our data suggests that delivery vehicles based on synthetic quaternary structures that exhibit higher-order architecture may be effective in improving delivery and release of nucleic acid cargo.


Subject(s)
Cell-Penetrating Peptides/metabolism , Collagen/metabolism , Gene Silencing , Gene Transfer Techniques , Polymers/metabolism , RNA, Small Interfering/genetics , Animals , Biological Transport , Biomimetic Materials/chemistry , Biomimetic Materials/metabolism , Capsid/chemistry , Carbocyanines/chemistry , Carbocyanines/metabolism , Cell-Penetrating Peptides/chemistry , Collagen/chemistry , Fluorescein-5-isothiocyanate/chemistry , Fluorescein-5-isothiocyanate/metabolism , Fluorescent Dyes/chemistry , Fluorescent Dyes/metabolism , Genes, Reporter , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Hydroxyproline/chemistry , Hydroxyproline/metabolism , Mice , Molecular Conformation , NIH 3T3 Cells , Nanoparticles/chemistry , Polymers/chemistry , RNA, Small Interfering/metabolism
10.
Epigenetics Chromatin ; 12(1): 54, 2019 09 11.
Article in English | MEDLINE | ID: mdl-31511048

ABSTRACT

BACKGROUND: Methylation of cytosines is an evolutionarily conserved epigenetic mark that is essential for the control of chromatin activity in many taxa. It acts mainly repressively, causing transcriptional gene silencing. In plants, de novo DNA methylation is established mainly by RNA-directed DNA-methylation pathway. Even though the protein machinery involved is relatively well-described, the course of the initial phases remains covert. RESULTS: We show the first detailed description of de novo DNA-methylation dynamics. Since prevalent plant model systems do not provide the possibility to collect homogenously responding material in time series with short intervals, we developed a convenient system based on tobacco BY-2 cell lines with inducible production of siRNAs (from an RNA hairpin) guiding the methylation machinery to the CaMV 35S promoter controlling GFP reporter. These lines responded very synchronously, and a high level of promoter-specific siRNAs triggered rapid promoter methylation with the first increase observed already 12 h after the induction. The previous presence of CG methylation in the promoter did not affect the methylation dynamics. The individual cytosine contexts reacted differently. CHH methylation peaked at about 80% in 2 days and then declined, whereas CG and CHG methylation needed more time with CHG reaching practically 100% after 10 days. Spreading of methylation was only minimal outside the target region in accordance with the absence of transitive siRNAs. The low and stable proportion of 24-nt siRNAs suggested that Pol IV was not involved in the initial phases. CONCLUSIONS: Our results show that de novo DNA methylation is a rapid process initiated practically immediately with the appearance of promoter-specific siRNAs and independently of the prior presence of methylcytosines at the target locus. The methylation was precisely targeted, and its dynamics varied depending on the cytosine sequence context. The progressively increasing methylation resulted in a smooth, gradual inhibition of the promoter activity, which was entirely suppressed in 2 days.


Subject(s)
DNA Methylation , RNA, Small Interfering/metabolism , Caulimovirus/genetics , DNA Methylation/drug effects , Estradiol/pharmacology , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Plant Cells/metabolism , Plasmids/genetics , Plasmids/metabolism , Promoter Regions, Genetic , RNA Interference , RNA, Small Interfering/genetics , Nicotiana/cytology
11.
Curr Gene Ther ; 19(4): 274-287, 2019.
Article in English | MEDLINE | ID: mdl-31393245

ABSTRACT

BACKGROUND: Polyrotaxane, a macromolecular interlocked assembly, consisting of cyclodextrin has excellent inclusion capabilities and functionalization capacity, which makes it a versatile material as a vector for gene delivery applications. OBJECTIVE: A biodegradable linear aliphatic polyester axle composed of Polyethylene Glycol (PEG) and Sebacic Acid (SA) was used to fabricate the ß-Cyclodextrin (ß-CD) based polyrotaxane as a cationic polymeric vector and evaluated for its potential gene silencing efficiency. METHODS: The water-soluble aliphatic polyester was synthesized by the solvent esterification process and characterized using viscometry, GPC, FT-IR and 1H NMR spectroscopy. The synthesized polyester was further evaluated for its biodegradability and cellular cytotoxicity. Hence, this water-soluble polyester was used for the step-wise synthesis of polyrotaxane, via threading and blocking reactions. Threading of ß-CD over PEG-SA polyester axle was conducted in water, followed by end-capping of polypseudorotaxane using 2,4,6-trinitrobenzenesulfonic acid to yield polyester-based polyrotaxane. For gene delivery application, cationic polyrotaxane (PRTx+) was synthesized and evaluated for its gene loading and gene silencing efficiency. RESULTS AND DISCUSSION: The resulting novel macromolecular assembly was found to be safe for use in biomedical applications. Further, characterization by GPC and 1H NMR techniques revealed successful formation of PE-ß-CD-PRTx with a threading efficiency of 16%. Additionally, the cellular cytotoxicity assay indicated biosafety of the synthesized polyrotaxane, exploring its potential for gene delivery and other biomedical applications. Further, the biological profile of PRTx+: siRNA complexes was evaluated by measuring their zeta potential and gene silencing efficiency, which were found to be comparable to Lipofectamine 3000, the commercial transfecting agent. CONCLUSION: The combinatory effect of various factors such as biodegradability, favourable complexation ability, near zero zeta potentials, good cytotoxicity properties of poly (ethylene glycol)-sebacic acid based ß-Cyclodextrin-polyrotaxane makes it a promising gene delivery vector for therapeutic applications.


Subject(s)
Cyclodextrins/chemistry , Decanoic Acids/chemistry , Dicarboxylic Acids/chemistry , Gene Silencing , Green Fluorescent Proteins/antagonists & inhibitors , Poloxamer/chemistry , Polyethylene Glycols/chemistry , RNA, Small Interfering/genetics , Rotaxanes/chemistry , beta-Cyclodextrins/chemistry , Gene Transfer Techniques , Genetic Vectors/administration & dosage , Genetic Vectors/genetics , Green Fluorescent Proteins/genetics , HeLa Cells , Humans , Polyesters/chemistry , Polymers
12.
Biomacromolecules ; 20(8): 3076-3086, 2019 08 12.
Article in English | MEDLINE | ID: mdl-31305991

ABSTRACT

The use of small interfering RNA (siRNA) to regulate oncogenes appears as a promising strategy in the context of cancer therapy, especially if they are vectorized by a smart delivery system. In this study, we investigated the cellular trafficking of a siRNA nanovector (called CS-MSN) functionalized with the cell-penetrating peptide gH625 in a triple-negative breast cancer model. With complementary techniques, we showed that siRNA nanovectors were internalized by both clathrin- and caveolae-mediated endocytosis. The presence of gH625 at the surface of the siRNA nanovector did not modify the entry pathway of CS-MSN, but it increased the amount of siRNA found inside the cells. Results suggested an escape of siRNA from endosomes, which is enhanced by the presence of the peptide gH625, whereas nanoparticles continued their trafficking into lysosomes. The efficiency of CS-MSN to inhibit the GFP in MDA-MB-231 cells was 1.7-fold higher than that of the nanovectors without gH625.


Subject(s)
Cell-Penetrating Peptides/administration & dosage , Endocytosis , Endosomes/metabolism , Green Fluorescent Proteins/antagonists & inhibitors , Nanoparticles/administration & dosage , RNA, Small Interfering/administration & dosage , Triple Negative Breast Neoplasms/metabolism , Cell Movement , Female , Gene Silencing , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Lysosomes/metabolism , Nanoparticles/chemistry , RNA, Small Interfering/genetics , Triple Negative Breast Neoplasms/genetics , Triple Negative Breast Neoplasms/pathology , Tumor Cells, Cultured
13.
J Cell Mol Med ; 23(3): 1784-1797, 2019 03.
Article in English | MEDLINE | ID: mdl-30548903

ABSTRACT

Aberrant regulation of programmed cell death (PCD) has been tied to an array of human pathologies ranging from cancers to autoimmune disorders to diverse forms of neurodegeneration. Pharmacologic modulation of PCD signalling is therefore of central interest to a number of clinical and biomedical applications. A key component of PCD signalling involves the modulation of pro- and anti-apoptotic Bcl-2 family members. Among these, Bax translocation represents a critical regulatory phase in PCD. In the present study, we have employed a high-content high-throughput screen to identify small molecules which inhibit the cellular process of Bax re-distribution to the mitochondria following commitment of the cell to die. Screening of 6246 Generally Recognized As Safe compounds from four chemical libraries post-induction of cisplatin-mediated PCD resulted in the identification of 18 compounds which significantly reduced levels of Bax translocation. Further examination revealed protective effects via reduction of executioner caspase activity and enhanced mitochondrial function. Consistent with their effects on Bax translocation, these compounds exhibited significant rescue against in vitro and in vivo cisplatin-induced apoptosis. Altogether, our findings identify a new set of clinically useful small molecules PCD inhibitors and highlight the role which cAMP plays in regulating Bax-mediated PCD.


Subject(s)
Cell Proliferation/drug effects , Green Fluorescent Proteins/antagonists & inhibitors , High-Throughput Screening Assays/methods , Protein Transport/drug effects , Small Molecule Libraries/pharmacology , bcl-2-Associated X Protein/antagonists & inhibitors , Animals , CHO Cells , Cricetulus , Green Fluorescent Proteins/metabolism , Humans , bcl-2-Associated X Protein/metabolism
14.
Sci Rep ; 8(1): 7738, 2018 05 17.
Article in English | MEDLINE | ID: mdl-29773839

ABSTRACT

For tissue engineering applications, small interfering RNA (siRNA) is an attractive agent for controlling cellular functions and differentiation. Although polyionic condensation of nucleic acids with polycations has been widely used for gene delivery, siRNA is not strongly associated with cationic carriers due to its low charge density and rigid molecular structures. The use of an excess amount of cationic carriers is often used for siRNA condensation, though they can induce severe cytotoxicity. Here we introduce the self-assembly of siRNA with mild polyelectrolytes into multilayers for efficient gene silencing during cell proliferation. The multilayers were prepared through the sequential layer-by-layer deposition of siRNA and poly-L-lysine (PLL) on a polydopamine-coated substrate. The cells, grown on the siRNA/PLL multilayers, exhibited a remarkable inhibition of the expression of target genes as compared to the use of scrambled siRNA. The gene silencing efficiency depends on the number of siRNA layers within a multilayer. This result indicates that siRNA/PLL multilayers can be potentially utilized for efficient surface-mediated siRNA delivery.


Subject(s)
Cell Adhesion , Cell Survival , Gene Silencing , Green Fluorescent Proteins/antagonists & inhibitors , Indoles/chemistry , Polylysine/chemistry , Polymers/chemistry , RNA, Small Interfering/genetics , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HeLa Cells , Humans
15.
Proc Natl Acad Sci U S A ; 115(20): 5235-5240, 2018 05 15.
Article in English | MEDLINE | ID: mdl-29695630

ABSTRACT

Reef-building corals are critically important species that are threatened by anthropogenic stresses including climate change. In attempts to understand corals' responses to stress and other aspects of their biology, numerous genomic and transcriptomic studies have been performed, generating a variety of hypotheses about the roles of particular genes and molecular pathways. However, it has not generally been possible to test these hypotheses rigorously because of the lack of genetic tools for corals. Here, we demonstrate efficient genome editing using the CRISPR/Cas9 system in the coral Acropora millepora We targeted the genes encoding fibroblast growth factor 1a (FGF1a), green fluorescent protein (GFP), and red fluorescent protein (RFP). After microinjecting CRISPR/Cas9 ribonucleoprotein complexes into fertilized eggs, we detected induced mutations in the targeted genes using changes in restriction-fragment length, Sanger sequencing, and high-throughput Illumina sequencing. We observed mutations in ∼50% of individuals screened, and the proportions of wild-type and various mutant gene copies in these individuals indicated that mutation induction continued for at least several cell cycles after injection. Although multiple paralogous genes encoding green fluorescent proteins are present in A. millepora, appropriate design of the guide RNA allowed us to induce mutations simultaneously in more than one paralog. Because A. millepora larvae can be induced to settle and begin colony formation in the laboratory, CRISPR/Cas9-based gene editing should allow rigorous tests of gene function in both larval and adult corals.


Subject(s)
CRISPR-Cas Systems , Coral Reefs , Fibroblast Growth Factor 1/antagonists & inhibitors , Gene Editing , Green Fluorescent Proteins/antagonists & inhibitors , Luminescent Proteins/antagonists & inhibitors , Mutation , Animals , Base Sequence , Fibroblast Growth Factor 1/genetics , Genome , Genomics , Green Fluorescent Proteins/genetics , Luminescent Proteins/genetics , Phenotype , Sequence Homology , Red Fluorescent Protein
16.
Br J Pharmacol ; 175(13): 2662-2675, 2018 07.
Article in English | MEDLINE | ID: mdl-29582417

ABSTRACT

BACKGROUND AND PURPOSE: The nociceptin/orphanin FQ opioid peptide (NOP) receptor system plays a significant role in the regulation of pain. This system functions differently in the spinal cord and brain. The mechanism by which the NOP receptor agonists regulate pain transmission in these regions is not clearly understood. Here, we investigate the peripheral and spinal NOP receptor distribution and antinociceptive effects of intrathecal nociceptin/orphanin FQ (N/OFQ) in chronic neuropathic pain. EXPERIMENTAL APPROACH: We used immunohistochemistry to determine changes in NOP receptor distribution triggered by spinal nerve ligation (SNL) using NOP-eGFP knock-in mice. Antinociceptive effects of intrathecal N/OFQ on SNL-mediated allodynia and heat/cold hyperalgesia were assessed in wild-type mice. KEY RESULTS: NOP-eGFP immunoreactivity was decreased by SNL in the spinal laminae I and II outer, regions that mediate noxious heat stimuli. In contrast, immunoreactivity of NOP-eGFP was unchanged in the ventral border of lamina II inner, which is an important region for the development of allodynia. NOP-eGFP expression was also decreased in a large number of primary afferents in the L4 dorsal root ganglion (DRG) of SNL mice. However, SNL mice showed increased sensitivity, compared to sham animals to the effects of i.t administered N/OFQ with respect to mechanical as well as thermal stimuli. CONCLUSIONS AND IMPLICATIONS: Our findings suggest that the spinal NOP receptor system attenuates injury-induced hyperalgesia by direct inhibition of the projection neurons in the spinal cord that send nociceptive signals to the brain and not by inhibiting presynaptic terminals of DRG neurons in the superficial lamina.


Subject(s)
Chronic Pain/drug therapy , Disease Models, Animal , Opioid Peptides/antagonists & inhibitors , Receptors, Opioid/analysis , Spinal Cord/chemistry , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/chemistry , Analgesics, Opioid/pharmacology , Animals , Chronic Pain/metabolism , Female , Gene Knock-In Techniques , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/metabolism , Injections, Spinal , Male , Mice , Mice, Inbred C57BL , Opioid Peptides/metabolism , Receptors, Opioid/metabolism , Spinal Cord/drug effects , Nociceptin Receptor
17.
Nanomedicine ; 14(1): 97-108, 2018 01.
Article in English | MEDLINE | ID: mdl-28917642

ABSTRACT

CRISPR-Cas9 is a revolutionary genome-editing technology that has enormous potential for the treatment of genetic diseases. However, the lack of efficient and safe, non-viral delivery systems has hindered its clinical application. Here, we report on the application of polymeric and hybrid microcarriers, made of degradable polymers such as polypeptides and polysaccharides and modified by silica shell, for delivery of all CRISPR-Cas9 components. We found that these microcarriers mediate more efficient transfection than a commercially available liposome-based transfection reagent (>70% vs. <50% for mRNA, >40% vs. 20% for plasmid DNA). For proof-of-concept, we delivered CRISPR-Cas9 components using our capsules to dTomato-expressing HEK293T cells-a model, in which loss of red fluorescence indicates successful gene editing. Notably, transfection of indicator cells translated in high-level dTomato knockout in approx. 70% of transfected cells. In conclusion, we have provided proof-of-principle that our micro-sized containers represent promising non-viral platforms for efficient and safe gene editing.


Subject(s)
CRISPR-Cas Systems , Gene Editing , Polymers/chemistry , Solanum lycopersicum/metabolism , Drug Carriers , Fluorescence , Gene Transfer Techniques , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , Solanum lycopersicum/genetics , Silicon Dioxide/chemistry
18.
J Colloid Interface Sci ; 512: 335-345, 2018 Feb 15.
Article in English | MEDLINE | ID: mdl-29080529

ABSTRACT

Chitosan (CS)/siRNA polyplexes have great therapeutic potential for treating multiple diseases by gene silencing. However, clinical application of this technology requires the development of concentrated, hemocompatible, pH neutral formulations for safe and efficient administration. In this study we evaluate physicochemical properties of chitosan polyplexes in various buffers at increasing ionic strengths, to identify conditions for freeze-drying and rehydration at higher doses of uncoated or hyaluronic acid (HA)-coated polyplexes while maintaining physiological compatibility. Optimized formulations are used to evaluate the impact of the siRNA/oligonucleotide sequence on polyplex physicochemical properties, and to measure their in vitro silencing efficiency, cytotoxicity, and hemocompatibility. Specific oligonucleotide sequences influence polyplex physical properties at low N:P ratios, as well as their stability during freeze-drying. Nanoparticles display greater stability for oligodeoxynucleotides ODN vs siRNA; AT-rich vs GC-rich; and overhangs vs blunt ends. Using this knowledge, various CS/siRNA polyplexes are prepared with and without HA coating, freeze-dried and rehydrated at increased concentrations using reduced rehydration volumes. These polyplexes are non-cytotoxic and preserve silencing activity even after rehydration to 20-fold their initial concentration, while HA-coated polyplexes at pH∼7 also displayed increased hemocompatibility. These concentrated formulations represent a critical step towards clinical development of chitosan-based oligonucleotide intravenous delivery systems.


Subject(s)
Carcinoma, Non-Small-Cell Lung/pathology , Chitosan/chemistry , Green Fluorescent Proteins/antagonists & inhibitors , Hyaluronic Acid/chemistry , Oligonucleotides/chemistry , RNA, Small Interfering/administration & dosage , Buffers , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/genetics , Freeze Drying , Hemagglutination/drug effects , Hemolysis/drug effects , Humans , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Nanoparticles/administration & dosage , Nanoparticles/chemistry , RNA, Small Interfering/chemistry , RNA, Small Interfering/genetics , Tumor Cells, Cultured
19.
Amino Acids ; 49(5): 995-1004, 2017 05.
Article in English | MEDLINE | ID: mdl-28283906

ABSTRACT

Chloramphenicol peptides were recently established as useful tools for probing nascent polypeptide chain interaction with the ribosome, either biochemically, or structurally. Here, we present a new 10mer chloramphenicol peptide, which exerts a dual inhibition effect on the ribosome function affecting two distinct areas of the ribosome, namely the peptidyl transferase center and the polypeptide exit tunnel. According to our data, the chloramphenicol peptide bound on the chloramphenicol binding site inhibits the formation of both acetyl-phenylalanine-puromycin and acetyl-lysine-puromycin, showing, however, a decreased peptidyl transferase inhibition compared to chloramphenicol-mediated inhibition per se. Additionally, we found that the same compound is a strong inhibitor of green fluorescent protein synthesis in a coupled in vitro transcription-translation assay as well as a potent inhibitor of lysine polymerization in a poly(A)-programmed ribosome, showing that an additional inhibitory effect may exist. Since chemical protection data supported the interaction of the antibiotic with bases A2058 and A2059 near the entrance of the tunnel, we concluded that the extra inhibition effect on the synthesis of longer peptides is coming from interactions of the peptide moiety of the drug with residues comprising the ribosomal tunnel, and by filling up the tunnel and blocking nascent chain progression through the restricted tunnel. Therefore, the dual interaction of the chloramphenicol peptide with the ribosome increases its inhibitory effect and opens a new window for improving the antimicrobial potency of classical antibiotics or designing new ones.


Subject(s)
Chloramphenicol/pharmacology , Fluorenes/chemistry , Peptides/pharmacology , Protein Biosynthesis/drug effects , Protein Synthesis Inhibitors/pharmacology , Ribosomes/drug effects , Amino Acid Sequence , Binding Sites , Chloramphenicol/analogs & derivatives , Chloramphenicol/chemical synthesis , Escherichia coli K12/chemistry , Escherichia coli K12/genetics , Escherichia coli K12/metabolism , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Internal Ribosome Entry Sites/drug effects , Models, Molecular , Peptides/chemical synthesis , Peptidyl Transferases/antagonists & inhibitors , Peptidyl Transferases/genetics , Peptidyl Transferases/metabolism , Poly A/genetics , Poly A/metabolism , Protein Binding , Protein Synthesis Inhibitors/chemical synthesis , Puromycin/pharmacology , Ribosomes/genetics , Ribosomes/metabolism
20.
Molecules ; 22(1)2017 Jan 04.
Article in English | MEDLINE | ID: mdl-28054985

ABSTRACT

The efficient delivery of sufficient amounts of nucleic acids into target cells is critical for successful gene therapy and gene knockdown. The DNA/siRNA co-delivery system has been considered a promising approach for cancer therapy to simultaneously express and inhibit tumor suppressor genes and overexpressed oncogenes, respectively, triggering synergistic anti-cancer effects. Polyethylenimine (PEI) has been identified as an efficient non-viral vector for transgene expression. In this study, we created a very high efficient DNA/siRNA co-delivery system by incorporating a negatively-charged poly-γ-glutamic acid (γ-PGA) into PEI/nucleic acid complexes. Spherical nanoparticles with about 200 nm diameter were formed by mixing PEI/plasmid DNA/siRNA/γ-PGA (dual delivery nanoparticles; DDNPs) with specific ratio (N/P/C ratio) and the particles present positive surface charge under all manufacturing conditions. The gel retardation assay shows both nucleic acids were effectively condensed by PEI, even at low N/P ratios. The PEI-based DDNPs reveal excellent DNA/siRNA transfection efficiency in the human hepatoma cell line (Hep 3B) by simultaneously providing high transgene expression efficiency and high siRNA silencing effect. The results indicated that DDNP can be an effective tool for gene therapy against hepatoma.


Subject(s)
Nanoparticles/chemistry , Plasmids/metabolism , Polyethyleneimine/chemistry , Polyglutamic Acid/analogs & derivatives , RNA, Small Interfering/genetics , Transfection/methods , Biological Transport , Cell Line, Tumor , Gene Expression , Gene Silencing , Genes, Reporter , Green Fluorescent Proteins/antagonists & inhibitors , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hepatocytes/cytology , Hepatocytes/metabolism , Humans , Luminescent Proteins/antagonists & inhibitors , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Nanoparticles/ultrastructure , Plasmids/chemistry , Polyglutamic Acid/chemistry , RNA, Small Interfering/chemistry , RNA, Small Interfering/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...